These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1721938)

  • 1. [Role of membrane molecules in complement system].
    Okada N
    Rinsho Byori; 1991 Sep; Suppl 91():129-39. PubMed ID: 1721938
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte membrane protein deficiencies in paroxysmal nocturnal hemoglobinuria.
    Schultz DR
    Am J Med; 1989 Sep; 87(3N):22N-29N. PubMed ID: 2484793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms by which the erythrocyte protects itself from complement damage.
    Nicholson-Weller A; Halperin JA
    Prog Clin Biol Res; 1989; 297():263-70; discussion 270-1. PubMed ID: 2479950
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence that double transfection to xenoendothelial cells using GPI-anchoring complement regulatory factor (decay-accelerating factor and homologous restriction factor 20) gene is useful for the inhibition of human complement-mediated cytolysis.
    Hayashi S; Isobe K; Emi N; Okada H; Yasutomi M; Negita M; Koike C; Uchida K; Yokoyama I; Takagi H
    Transplant Proc; 1995 Feb; 27(1):330. PubMed ID: 7533402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Membrane-attacking complexes and membrane complement inhibitors on the leukocyte surface during combined exposure with meningococcus lipopolysaccharide and complement].
    Platonov AE; Vershinina IV; Serebrovskaia LV; Shepeleva GK
    Biull Eksp Biol Med; 1999 Apr; 127(4):433-8. PubMed ID: 10367130
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic inhibition of the complement system.
    Makrides SC
    Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complement regulatory factors and immunologic recognition mechanism between species].
    Seya T; Matsunoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
    [No Abstract]   [Full Text] [Related]  

  • 9. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F; Macor P; Bulla R; Sblattero D; Marzari R; Tedesco F
    Eur J Immunol; 2005 Jul; 35(7):2175-83. PubMed ID: 15971270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complement and bio-phylaxis].
    Nihon Rinsho; 1990 Jul; 48 Suppl():342-440. PubMed ID: 2214200
    [No Abstract]   [Full Text] [Related]  

  • 11. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
    Loveland BE; Szokolai K; Johnstone RW; McKenzie IF
    Transplant Proc; 1994 Jun; 26(3):1070-1. PubMed ID: 7518104
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
    Miyagawa S; Shirakura R; Nakata S; Izutani H; Matsuda H; Iwata K; Nagasawa S; Terado A; Hatanaka M; Matsumoto M
    Transplant Proc; 1995 Feb; 27(1):328-9. PubMed ID: 7533401
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic defense mechanism of non-antibody-dependent complement reactions].
    Nomoto K
    Nihon Rinsho; 1988 Sep; 46(9):1949-54. PubMed ID: 2468005
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A; Junnikkala S; Hakulinen J; Timonen T; Meri S
    Am J Pathol; 1996 Apr; 148(4):1139-52. PubMed ID: 8644856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible role of membrane complement regulators in vasculitis.
    Daha MR
    Behring Inst Mitt; 1993 Aug; (92):184-90. PubMed ID: 7504449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerulonephritis and complement regulatory proteins.
    Nangaku M; Johnson RJ; Couser WG
    Exp Nephrol; 1997; 5(5):345-54. PubMed ID: 9386969
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement inhibition: a new therapeutic modality?].
    Porcel JM
    Med Clin (Barc); 1995 Nov; 105(18):700-2. PubMed ID: 8538252
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of complement in glomerulonephritis.
    Simpson IJ
    Aust N Z J Med; 1981; 11(Suppl 1):101-3. PubMed ID: 6942797
    [No Abstract]   [Full Text] [Related]  

  • 20. Homologous restriction factor.
    Zalman LS
    Curr Top Microbiol Immunol; 1992; 178():87-99. PubMed ID: 1424777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.